In contrast, lower expression of the downregulated genes (such as SCARA5, MYOM1, NKAPL, PEG3, USP2, SLC5A7 and HMGCLL1) in various cancers is associated with poor clinical outcomes in cancer (Supplementary Figure 1). This evidence concerns the gene SLC5A7 and cancer.